Acute oliguric renal failure due to accelerated (malignant) hypertension.
D058186:Acute Kidney Injury / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D000293:Adolescent; D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001002:Anuria / Q000209:etiology; D001806:Blood Urea Nitrogen; D003981:Diazoxide / Q000627:therapeutic use; D005260:Female; D005919:Glomerular Filtration Rate; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D006830:Hydralazine / Q000627:therapeutic use; D006974:Hypertension, Malignant / Q000150:complications* / Q000188:drug therapy; D007684:Kidney Tubules / Q000473:pathology; D008297:Male; D008750:Methyldopa / Q000627:therapeutic use; D008875:Middle Aged; D010425:Pentolinium Tartrate / Q000627:therapeutic use; D010530:Peritoneal Dialysis
D000959:Antihypertensive Agents; D006146:Guanidines; D006830:Hydralazine; D008750:Methyldopa; D010425:Pentolinium Tartrate; D003981:Diazoxide